COMBINATION DRUG THERAPIES

\kˌɒmbɪnˈe͡ɪʃən dɹˈʌɡ θˈɛɹəpɪz], \kˌɒmbɪnˈe‍ɪʃən dɹˈʌɡ θˈɛɹəpɪz], \k_ˌɒ_m_b_ɪ_n_ˈeɪ_ʃ_ə_n d_ɹ_ˈʌ_ɡ θ_ˈɛ_ɹ_ə_p_ɪ_z]\

Definitions of COMBINATION DRUG THERAPIES

Sort: Oldest first
 
2010 - Medical Dictionary Database
By DataStellar Co., Ltd

Word of the day

Proto Oncogene Proteins c erbB 2

  • cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
View More